NCT07418385 Voluntary HIV Screening in the General Population in France
| NCT ID | NCT07418385 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université de Reims Champagne-Ardenne |
| Condition | Human Immunodeficiency Virus (HIV) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-10-07 |
| Primary Completion | 2026-04-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-10-07 with a primary completion date of 2026-04-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed. Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Male or female * Regardless of sexual orientation * Whether or not they have previously undergone voluntary HIV testing * Agreeing to participate in the study. Exclusion Criteria: * Minors * Refusing to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07418385 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Human Immunodeficiency Virus (HIV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07418385 currently recruiting?
Yes, NCT07418385 is actively recruiting participants. Contact the research team at currs@univ-reims.fr for enrollment information.
Where is the NCT07418385 trial being conducted?
This trial is being conducted at Reims, France.
Who is sponsoring the NCT07418385 clinical trial?
NCT07418385 is sponsored by Université de Reims Champagne-Ardenne. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.